Litcius/Paper detail

Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial

Xue Meng, Anping Zheng, Jun Wang, Xiao‐Yuan Wu, Guang Li, Jun Zhu, Hu Ma, Xiaodong Zhu, Anhui Shi, Chunhua Dai, Senxiang Yan, Buhai Wang, Zhongyu Qu, Chun Han, Xindong Sun, Ming Ye, Ruitai Fan, Niyazi Huerxidan, Xiaohong Wang, Jinming Yu

2023British Journal of Cancer22 citationsDOIOpen Access PDF

Topics & Concepts

NimotuzumabInterim analysisMedicinePlaceboInternal medicineClinical endpointPhases of clinical researchAdverse effectRadiation therapyClinical trialSurgeryOncologyGastroenterologyCancerPathologyEpidermal growth factor receptorAlternative medicineEsophageal Cancer Research and TreatmentCancer Immunotherapy and BiomarkersColorectal and Anal Carcinomas
Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial | Litcius